Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Haematology

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

TRM · newly diagnosed or relapsed patients with CLL

The intervention showed no clear difference in TRM (low certainty).

1 finding from 1 review

TRM · newly diagnosed or relapsed patients with CLL

The intervention showed no clear difference in TRM (moderate certainty).

1 finding from 1 review

Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia 2012 · Cochrane Headline outcomes only
RR 1.19 [0.7, 2.01]
3 studies · 1415 participants
Moderate